Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, DoubleRainbow Biosciences is raising $20,000,000.00 in new funding. Sources indicate as part of senior management President, Wan Yu played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About DoubleRainbow Biosciences

DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry from the natural world to benefit people’s lives. Rooted in the mechanistic understanding of specialized metabolic systems in plants and other organisms, we devise novel biosynthetic strategies that provide sustainable access to high-value natural products of medicinal or industrial significance.

To learn more about DoubleRainbow Biosciences, visit http://www.doublerainbowbio.com/

Contact:
Wan Yu, President
617-945-9790

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved